Micro-Hall Magnetometry Studies of Thermally Assisted and Pure Quantum Tunneling in Single Molecule Magnet Mn12-Acetate

We have studied the crossover between thermally assisted and pure quantum tunneling in single crystals of high spin (S=10) uniaxial single molecule magnet Mn12-acetate using micro-Hall effect magnetometry. Magnetic hysteresis experiments have been used toinvestigate the energy levels that determine the magnetization reversal as a function of magnetic field and temperature. These experiments demonstrate that the crossover occurs in a narrow (~0.1 K) or broad (~1 K) temperature interval depending on the magnitude and direction of the applied field. For low external fields applied parallel to the easy axis, the energy levels that dominate the tunneling shift abruptly with temperature. In the presence of a transverse field and/or large longitudinal field these energy levels change with temperature more gradually. A comparison of our experimental results with model calculations of this crossover suggest that there are additional mechanisms that enhance the tunneling rate of low lying energy levels and broaden the crossover for small transverse fields.Comment: 5 pages, 5 figure

The HLA class II allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and medically refractory lung disease with a grim prognosis. Although the etiology of IPF remains perplexing, abnormal adaptive immune responses are evident in many afflicted patients. We hypothesized that perturbations of human leukocyte antigen (HLA) allele frequencies, which are often seen among patients with immunologic diseases, may also be present in IPF patients. Methods/Principal Findings: HLA alleles were determined in subpopulations of IPF and normal subjects using molecular typing methods. HLA-DRB1*15 was over-represented in a discovery cohort of 79 Caucasian IPF subjects who had lung transplantations at the University of Pittsburgh (36.7%) compared to normal reference populations. These findings were prospectively replicated in a validation cohort of 196 additional IPF subjects from four other U.S. medical centers that included both ambulatory patients and lung transplantation recipients. High-resolution typing was used to further define specific HLA-DRB1*15 alleles. DRB1*1501 prevalence in IPF subjects was similar among the 143 ambulatory patients and 132 transplant recipients (31.5% and 34.8%, respectively, p = 0.55). The aggregate prevalence of DRB1*1501 in IPF patients was significantly greater than among 285 healthy controls (33.1% vs. 20.0%, respectively, OR 2.0; 95%CI 1.3-2.9, p = 0.0004). IPF patients with DRB1*1501 (n = 91) tended to have decreased diffusing capacities for carbon monoxide (DLCO) compared to the 184 disease subjects who lacked this allele (37.8±1.7% vs. 42.8±1.4%, p = 0.036). Conclusions/Significance: DRB1*1501 is more prevalent among IPF patients than normal subjects, and may be associated with greater impairment of gas exchange. These data are novel evidence that immunogenetic processes can play a role in the susceptibility to and/or manifestations of IPF. Findings here of a disease association at the HLA-DR locus have broad pathogenic implications, illustrate a specific chromosomal area for incremental, targeted genomic study, and may identify a distinct clinical phenotype among patients with this enigmatic, morbid lung disease

B decays

We review the prospects for B decay studies at the LHC. Contributing authors: J. Baines, S.P. Baranov, P. Bartalini, M. Beneke, E. Bouhova, G. Buchalla, I. Caprini, F. Charles, J. Charles, Y. Coadou, P. Colangelo, P. Colrain, J. Damet, F. De Fazio, A. Dighe, H. Dijkstra, P. Eerola, N. Ellis, B. Epp, S. Gadomski, P. Galumian, I. Gavrilenko, S. George, V.M. Ghete, V. Gibson, L. Guy, Y. Hasegawa, P. Iengo, A. Jacholkowska, R. Jones, A. Khodjamirian, E. Kneringer, P. Koppenburg, H. Korsmo, N. Labanca, L. Lellouch, M. Lehto, Y. Lemoigne, J. Libby, J. Matias, S. Mele, M. Misiak, A.M. Nairz, T. Nakada, A. Nikitenko, N. Nikitin, A. Nisati, F. Palla, E. Polycarpo, J. Rademacker, F. Rizatdinova, S. Robins, D. Rousseau, W. Ruckstuhl, M.A. Sanchis, O. Schneider, M. Shapiro, C. Shepherd-Themistocleous, P. Sherwood, L. Smirnova, M. Smizanska, A. Starodumov, N. Stepanov, Z. Xie, N. Zaitse